April 13, 2022 Comments Off on New patent for Exeltis Usa drug SLYND Posted in: Patent Added Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are six…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch – Make B…
April 13, 2022 Comments Off on New patent expiration for Tersera drug ZOLADEX Posted in: Uncategorized
Annual Drug Patent Expirations for ZOLADEX Zoladex is a drug marketed by Tersera and is included in two NDAs. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Tersera drug ZOLADEX appeared first o…
